Molmed Spa

Ospedale San Raffaele S.r.l.

Fondazione Centro San Raffaele Del Monte Tabor

Flavio Curnis

Angelo Corti

A pharmaceutical composition comprising a conjugate of a cytokine and a tumor targeting moiety (TTM) and a pharmaceutically acceptable excipient, wherein the cytokine is present in an amount which does not induce a negative feedback mechanism.

Immunoconjugates for the treatment of tumours

A product comprising a peptide that comprises a motif selected from a group consisting of isoDGR, NGR and DGR, wherein the peptide cyclized by joining the N- and C-termini of its main chain and wherein the cyclic peptide is joined to albumin.

Peptides for inhibiting tumor growth

Disclosed herein are peptides which include an isoDGR motif and which selectively inhibit &#x3b1;v&#x3b2;3 integrin. In some embodiments, the isoDGR motif results from the deamidation of an NGR motif.

Growing community of inventors

Milan, Italy

Flavio Curnis